RecruitingNCT07107607

Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)

Cannabis as an Anti-cancer Agent: A Review of Medical Records in Patients With Cancer to Assess Potential Anti-cancer Benefits From Using Cannabis

Sponsor

HealthPartners Institute

Enrollment

50 participants

Start Date

Mar 19, 2021

Study Type

OBSERVATIONAL

Conditions

Cancer Cancer (With or Without Metastasis)

Summary

The purpose of the study is to find out how cannabis may help control cancer growth by reviewing medical records of patients who report cannabis helped treat their cancer.

Eligibility

Inclusion Criteria3

diagnosed with cancer
have used any type of cannabis/marijuana, including those with cannabidiol (CBD) and/or tetrahydrocannabinol (THC) to treat their cancer
believe that cannabis has either stopped the tumor from growing and/or caused a cancer antigen blood marker to remain stable or cannabis has shrunken the tumor and/or caused reduction in a cancer antigen blood marker

Exclusion Criteria3

does not have cancer
has not used any type of cannabis/marijuana, including those with CBD and/or THC to treat their cancer
does not believe that cannabis has either stopped the tumor from growing and/or caused a cancer antigen blood marker to remain stable or cannabis has shrunken the tumor and/or caused reduction in a cancer antigen blood marker

Interested in this trial?

Get notified about updates and connect with the research team.